2020 (11th) International ConferenCE on CEll Therapy
Focus on stem CEll & regenerative medicine, CAR-T , canCEr immunotherapy, gene therapy, and more.
The Wuxi International Bioforum 2019 and The 9th CEll Death & Disease Symposium - New Drug Discovery
Internationally renowned leading scientists and pioneers will present cutting-edge advanCEs in canCEr immunotherapy, targeted therapy with small molecules,and/or monoclonal antibodies, and novel CEll therapeutic strategies. . New challenges, topical directions and novel approacheswill be discussed.
2019 (10th) International ConferenCE on CEll Therapy
Although CEll therapy has been on its fast lane, all colleagues in this field still have a long way to go due to the difficulty in treatment of solid tumors and the high cost of T CElls. It is believed that many people are looking forward to the approval of Chinese CEll therapy products.
2019 (5th) International ConferenCE on Gut Microecology and Health
At present, gut microbiome is a hot topic, which draws much attention. Due to its curative effects on multiple diseases, gut microbiome is closely related to human health. Under the development of microbe imaging, metabolomics and single-CEll sequencing technologies, new progress has been made in this field.
2018 (4th) International Symposium on Next-Generation CAR & TCR-T CElls
Chimeric antigen reCEptors are engineered reCEptors that combine a new specificity with an immune CEll to target canCEr CElls. Typically, these reCEptors graft the specificity of a monoclonal antibody onto a T CEll. CAR-T CElls are a new type of treatment that uses living CElls that have been transformed.
2018 ( 10th ) International ConferenCE on Stem CElls
After nearly 20 years' development, there have been almost 100 companies focusing on technology R&D on stem CElls, establishment of stem CEll banks and application of stem CElls. This conferenCE will facilitate communication and cooperation among researchers at home and abroad.
2018 International Symposium on Single-CEll Omics Technology and Application
ReCEnt technological advanCEs are providing unpreCEdented opportunities to analyse the complexities of biological systems at the single-CEll level. Various crucial biological phenomena are either invisible or only partially characterized when interrogated using standard analyses that average data across a bulk population of CElls.
2018 Symposium on CanCEr Evolution and Heterogeneity
Heterogeneity is a major challenge in canCEr treatment, which has a profound impact on canCEr evolution & metastasis and drug resistanCE. With the developments of new technologies, there emerge sucCEssive achievements with great significanCE on clinical therapeutics. This symposium will focus on canCEr heterogeneity, promoting the clinical translation of research.
2018 Symposium on Tumor Microenvironment and CanCEr Immunotherapy
With the approval of many PD-1 checkpoint inhibitors and the sucCEss of lots of clinical trials on canCEr immunotherapy, people become more confident with overwhelming the incurable disease. However, there still remain unsolved problems in tumor microenvironment & tumor immunity.